SCHEMBL4050348

SCHEMBL4050348

CNS(=O)(=O)c1ccc(OBOc2ccc(S(=O)(=O)NC)cc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.68
LMNA P02545 2/20 0.68
HTT P42858 1/20 0.68
GAA P10253 1/20 0.55
ALDH1A1 P00352 4/20 0.55
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
CA12 O43570 2/20 0.53
CA3 P07451 2/20 0.53
CA4 P22748 2/20 0.53
CA6 P23280 2/20 0.53
CA5A P35218 2/20 0.53
CA7 P43166 2/20 0.53
CA9 Q16790 2/20 0.53
CA13 Q8N1Q1 2/20 0.53
CA14 Q9ULX7 2/20 0.53
CA5B Q9Y2D0 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.47
NR3C2 P08235 1/20 0.44
MMP1 P03956 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1104955 0.82 SMN1; SMN2 (0.59) SMN1; SMN2LMNAHTTGAAALDH1A1
SCHEMBL17907417 0.81 SMN1; SMN2 (1.00) SMN1; SMN2LMNAHTTGAAALDH1A1
SCHEMBL7629070 0.80 SMN1; SMN2 (0.80) SMN1; SMN2LMNAHTTGAAALDH1A1
SCHEMBL6658719 0.79 ALDH1A1 (0.53) SMN1; SMN2LMNAHTTALDH1A1CA1
SCHEMBL4041550 0.79 ALDH1A1 (0.59) SMN1; SMN2LMNAHTTALDH1A1PKM
SCHEMBL1620820 0.79 SMN1; SMN2 (0.73) SMN1; SMN2LMNAHTTGAAALDH1A1
SCHEMBL15303538 0.78 L3MBTL1 (0.50) SMN1; SMN2LMNAHTTGAAL3MBTL1
SCHEMBL11514815 0.78 SMN1; SMN2 (0.70) SMN1; SMN2LMNAHTTGAAALDH1A1
SCHEMBL507649 0.77 ENPP2 (0.48) PKM
SCHEMBL7926322 0.77 CA12 (0.60) SMN1; SMN2LMNAHTTALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2020404-A1 Cyanomethyl substituted N-Acyl Tryptamines Bayer Schering Pharma Aktiengesellschaft (DE) 2009-02-04 EP disclosed